Officers, beneficial owners, and other insiders have shelled out more than $10 million on each of these four biotech stocks ...

Biopharmaceutical stocks that have lagged behind the broader market may finally have their day in the sun. BofA Securities ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

The term "game-changing" is overused for too many up-and-coming companies, but in this case, the description fits.

Quantum Biopharma Ltd. (NASDAQ:QNTM – Get Free Report)’s stock price dropped 4.8% during trading on Monday . The stock traded as low as $4.20 and last traded at $4.40. Approximately 38,219 shares ...

Equities research analysts at HC Wainwright issued their Q1 2025 earnings estimates for Xeris Biopharma in a research report issued on Friday, March 7th. HC Wainwright analyst O. Livnat anticipates ...

Maravai LifeSciences Holdings, Inc.’s MRVI share price has surged by 10.86%, which has investors questioning if this is right ...

Stevanato's 2024 revenue hits €1.1B, driven by biopharma growth! Discover how facility expansions & rising demand are ...

In contrast, there are also reverse stock splits that reduce the number of outstanding shares (consolidate). BEDMINSTER, N.J., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings ...

Benitec Biopharma Inc.’s BNTC share price has surged by 11.39%, which has investors questioning if this is right time to sell ...

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FSE: 0K91) (the "Company"), a biopharmaceutical company dedicated to ...

There's a perfectly good answer: Like so many other technology and biopharma stocks of its ilk and age, Recursion soared on hype before the world was fully ready to embrace its solution.